Alcidion Group Limited (ASX: ALC) - ETF Exposure
- Current share price for ALC : $0.098
Alcidion Group Limited (ALC) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is a Company that is engaged in the development and licensing of its healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its partners and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in Australia, New Zealand and the United Kingdom.
ALC General Information +
| ASX Code | ALC |
| Website | N/A |
| Industry/Sector | Health Care Technology |
| Market Cap ($M) | 132 |
| ALC Share Price | $0.098 |
| Day High | $0.098 |
| Day Low | $0.097 |
| Last Close | $0.098 |
| ALC Share Price Movement | - ( No change ) |
Prices as at 16:40, 14 Oct 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Already own an Australian ETF? You may already have meaningful exposure to ALC
Alcidion Group Limited (ALC) is held across 1 ETF spanning strategies that include health care technology exposure . Its weighting in those funds means performance can have an outsized influence - when ALC moves, funds like DACE that hold it can move with it.
For more concentrated exposure, ETFs such as DACE (Dimensional Australian Core Equity (Managed Fund)) allocate about 0% to ALC , while the average exposure across all 1 ETF that hold it is around 0% .
Top ETF holdings
Last updated: ETF data and holdings as at 14 October 2026
Own ALC directly or through an ETF?
How does holding Alcidion Group Limited (ALC) shares directly compare to ETFs that include it?
|
ALC Direct
|
DACE
ASX |
|
|---|---|---|
| Holdings | 1 company | 501 holdings |
| ALC Weight | 100% | 0% |
| Diversification | Single Stock | Broad |
| Annual Cost | Brokerage only | 0.28% p.a. |
| Approx. Yield | 0% | 3.19% |
| Star Ratings | - |  |
Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not ALC's direct yield. Annual cost uses each ETF's MER.
ALC Exposure on $10,000 investment
How a $10,000 investment in Alcidion Group Limited (ALC) one week ago compares with ETFs that hold it.
| Security | Investment type | Current price | 7-day price movement | Dollar change | Value today |
|---|---|---|---|---|---|
| Alcidion Group Limited (ALC) | Direct share | $0.098 | -6.67% | -$667 | $9,333 |
| Dimensional Australian Core Equity (Managed Fund) (DACE) | Equity - Australia Strategy | $18.480 | 0% | $0 | $10,000 |
Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.
Alcidion Group Limited (ALC) ETFs
1 ETF hold Alcidion Group Limited (ALC).
| ETF | ALC Weight | MER | Yield |
|---|---|---|---|
| Dimensional Australian Core Equity (Managed Fund) (DACE) | 0% | 0.28% | 3.19% |
Alcidion Group Limited (ALC) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Alcidion Group Limited (ALC) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Alcidion Group Limited (ALC) price-sensitive announcements
ALC - Proposed Consolidation of Capital
Alcidion Group Limited announced a proposed 1-for-10 consolidation of its issued capital,
Alcidion Group Limited (ALC)
9 Oct 2026 | 8:16 AM
9 Oct 2026 | 8:16 AM
ALC - 2026 Notice of Annual General Meeting
Alcidion Group Limited (ASX: ALC) announced its 2026 Notice of Annual General Meeting on 9
Alcidion Group Limited (ALC)
9 Oct 2026 | 8:16 AM
9 Oct 2026 | 8:16 AM
ALC - FY26 Results Presentation
Alcidion Group Limited's FY26 results show strong financial performance with a 27% increas
Alcidion Group Limited (ALC)
19 Aug 2026 | 8:00 AM
19 Aug 2026 | 8:00 AM
ALC - FY26 Results Release
Alcidion Group Limited reported a strong financial performance for FY26, with a revenue in
Alcidion Group Limited (ALC)
19 Aug 2026 | 8:00 AM
19 Aug 2026 | 8:00 AM
Alcidion Group Limited (ALC) Recent ASX Announcements
ALC Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2028F | C2 | $10.80 | 17.50% | 0.90 | 0.00 | 0.00% | 0.0% |
| 2027F | C2 | $9.20 | 4,475.00% | 1.10 | 0.00 | 0.00% | 0.0% |
| 2026A | $2.70 | $0.20 | 66.70% | 51.80 | 0.00 | 0.00% | 0.0% |
ALC Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 A | 2027 F | 2028 F | 2026 A | 2027 F | 2028 F | 2026 A | 2027 F | 2028 F | ||
| 4DMedical Limited (4DX) | $2,456M | 1.7823 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Alcidion Group Limited (ALC) | $135M | 0.6667 | 44.7500 | 0.1749 | 50.0000 | 1.0929 | 0.9302 | 0.00% | 0.00% | 0.00% |
| Artrya Limited (AYA) | $491M | -0.0450 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Pro Medicus Limited (PME) | $17,310M | 1.3034 | -0.2811 | 0.2395 | 65.3352 | 90.8837 | 73.3206 | 0.42% | 0.56% | 0.69% |
ALC Directors
| Name | Position | Start Date |
|---|---|---|
| Ms Katrina (Kate) Elizabeth Doyle (Quirke) | Chief Executive Officer, Executive Director, Managing Director | 3 Jul 2018 |
| Mr William (Bill) Smart | Non-Executive Director | 1 Oct 2024 |
| Mr Daniel Sharp | Non-Executive Director | 1 Sep 2021 |
| Professor Andrew Way | Non-Executive Director | 15 Apr 2025 |
| Ms Rebecca Jayne Wilson | Non-Executive Director, Non-Executive Chairman | 31 Jul 2017 |
Alcidion Group Limited (ALC) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 5 Oct 2026 | SMART, William (Bill) | Buy | Indirect Shares | 200,000 | $0.104 | $20,851.880 |
| 26 Aug 2026 | WAY, Andrew | Buy | Direct Shares | 107,526 | $0.093 | $9,999.918 |
| 26 Aug 2026 | WAY, Andrew | Buy | Direct Shares | 107,526 | $0.093 | $9,999.918 |
See all changes in directors' interest & trades for Alcidion Group Limited (ALC) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
ALC Management
| Name | Position |
|---|---|
| Matthew Gepp | CFO |
| Michael Sapountzis | Company Secretary |
ALC Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Alcidion Group Limited (ALC). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 126,691,397 (9.43%) | AustralianSuper Pty Limited |
| 106,416,160 (7.92%) | Malcolm Pradhan |
ALC Calendar of Events
| Date | Event |
|---|---|
| 18 August 2027 | Report (Annual) |
| 18 August 2027 | Report (Prelim) |
| 25 February 2027 | Report (Interim) |
| 12 November 2026 | AGM |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
